Trial · NCT01906489
Results by group186
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 186
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants Achieving a Successful Hemoglobin Response | Vadadustat | 54.9 | Percentage of participants | ||
| Percentage of Participants Achieving a Successful Hemoglobin Response | Placebo | 10.3 | Percentage of participants | ||
| Percentage of Participants With Hemoglobin Value ≥13.0 g/dL at Any Time During the Study | Vadadustat | 59.6 | Percentage of participants | ||
| Percentage of Participants With Hemoglobin Value ≥13.0 g/dL at Any Time During the Study | Placebo | 88.9 | Percentage of participants | ||
| Percentage of Participants Achieving a Successful Hemoglobin Response, Determined Solely Based on the Hemoglobin Value | Vadadustat | 44.9 | Percentage of participants | ||
| Percentage of Participants Achieving a Successful Hemoglobin Response, Determined Solely Based on the Hemoglobin Value | Placebo | 13.9 | Percentage of participants | ||
| Percentage of Participants Achieving a Successful Hemoglobin Response in ESA Treatment naïve Group | Vadadustat | 50 | Percentage of participants | ||
| Percentage of Participants Achieving a Successful Hemoglobin Response in ESA Treatment naïve Group | Placebo | 7.9 | Percentage of participants | ||
| Percentage of Participants Achieving a Successful Hemoglobin Response in ESA Previously Treated Group | Vadadustat | 41.5 | Percentage of participants | ||
| Percentage of Participants Achieving a Successful Hemoglobin Response in ESA Previously Treated Group | Placebo | 19 | Percentage of participants | ||
| Percentage of Participants Achieving a Successful Hemoglobin Response in ESA Actively Treated Group | Vadadustat | 33.3 | Percentage of participants | ||
| Percentage of Participants Achieving a Successful Hemoglobin Response in ESA Actively Treated Group | Placebo | 7.7 | Percentage of participants | ||
| Percentage of Participants Achieving a Successful Hemoglobin Response, Analyzed in mITT Population | Vadadustat | 44.1 | Percentage of participants | ||
| Percentage of Participants Achieving a Successful Hemoglobin Response, Analyzed in mITT Population | Placebo | 11.1 | Percentage of participants | ||
| Change From Baseline in Hemoglobin | Vadadustat | Baseline | 9.94 | Standard Deviation 0.861 | g/dL |
| Change From Baseline in Hemoglobin | Placebo | Baseline | 9.96 | Standard Deviation 0.790 | g/dL |
| Change From Baseline in Hemoglobin | Vadadustat | Week 2 | 0.1 | Standard Deviation 0.756 | g/dL |
| Change From Baseline in Hemoglobin | Placebo | Week 2 | -0.22 | Standard Deviation 0.564 | g/dL |
| Change From Baseline in Hemoglobin | Vadadustat | Week 4 | 0.39 | Standard Deviation 0.868 | g/dL |
| Change From Baseline in Hemoglobin | Placebo | Week 4 | -0.25 | Standard Deviation 0.679 | g/dL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01906489/results